Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERTY: VYD2311 and COVID-19 Vaccine in Healthy Participants
NCT07655180Phase 3Completed
- Sponsor
- Invivyd
- Start
- Jun 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
A Phase 3 trial of VYD2311 in coronavirus disease 2019 (COVID-19), sponsored by Invivyd. Started Jun 2026; status: completed.
02
Drugs
VYD2311
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07655180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07655180.